FLUNEX 50 MG / ML SOLUTION FOR INJECTION FOR CATTLE, HORSES AND PIGS
FLUNEX 50 MG / ML SOLUTION FOR INJECTION FOR CATTLE, HORSES AND PIGS
Authorised
- Flunixin meglumine
Product identification
Medicine name:
FLUNEX 50 MG / ML SOLUTION FOR INJECTION FOR CATTLE, HORSES AND PIGS
Eflunex, 50 mg/ml süstelahus veistele, hobustele ja sigadele
Active substance:
- Flunixin meglumine
Target species:
-
Cattle
-
Pig
-
Horse
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Flunixin meglumine82.90/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal31day
-
Milk36hour
-
-
Pig
-
Meat and offal24day
-
-
-
Intravenous use
-
Cattle
-
Meat and offal4day
-
Milk24hour
-
-
Horse
-
Milkno withdrawal periodNot authorised for use in mares producing milk for human consumption.
-
Meat and offal5day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AG90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Package description:
- 1x50 ml vial
- 1x100 ml vial
- 1x250 ml vial
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Industrial Veterinaria S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- aniMedica GmbH
- Industrial Veterinaria S.A.
- aniMedica Herstellungs GmbH
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1181624
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0474/001
Concerned member states:
-
Austria
-
Cyprus
-
Czechia
-
Estonia
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Spain
-
United Kingdom (Northern Ireland)
Generic of:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 26/08/2025